Phase II trial of oxaliplatin/irinotecan/5-fluorouracil/leucovorin for metastatic colorectal cancer.
- Citation:
- Clin Colorectal Cancer vol 6 (7) 516-21
- Year:
- 2007
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- 519
- Children:
- None
- Pharmas:
- Grants:
- CA25224, CA35195, CA35269, CA35431, CA37404
- Corr. Author:
- Authors:
- Robert R McWilliams Matthew P Goetz Bruce W Morlan Muhammad Salim Kendrith M Rowland James E Krook Matthew M Ames Charles Erlichman
- Networks:
- Study
- NCCTG-N0341
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Aged, Antineoplastic Combined Chemotherapy Protocols, Camptothecin, Colorectal Neoplasms, Female, Fluorouracil, Humans, Leucovorin, Male, Middle Aged, Organoplatinum Compounds, Prognosis, Survival Rate, Treatment Outcome